Professional Documents
Culture Documents
EDITOR
New York Chicago San Francisco Lisbon London Madrid Mexico City
New Delhi San Juan Seoul Singapore Sydney Toronto
ISBN: 978-1-26-046811-3
MHID: 1-26-046811-9
The material in this eBook also appears in the print version of this title: ISBN: 978-1-26-046810-6,
MHID: 1-26-046810-0.
All trademarks are trademarks of their respective owners. Rather than put a trademark symbol after every oc-
currence of a trademarked name, we use names in an editorial fashion only, and to the benefit of the trademark
owner, with no intention of infringement of the trademark. Where such designations appear in this book, they
have been printed with initial caps.
McGraw-Hill Education eBooks are available at special quantity discounts to use as premiums and sales pro-
motions or for use in corporate training programs. To contact a representative, please visit the Contact Us page
at www.mhprofessional.com.
TERMS OF USE
This is a copyrighted work and McGraw-Hill Education and its licensors reserve all rights in and to the work.
Use of this work is subject to these terms. Except as permitted under the Copyright Act of 1976 and the right
to store and retrieve one copy of the work, you may not decompile, disassemble, reverse engineer, reproduce,
modify, create derivative works based upon, transmit, distribute, disseminate, sell, publish or sublicense the
work or any part of it without McGraw-Hill Education’s prior consent. You may use the work for your own
noncommercial and personal use; any other use of the work is strictly prohibited. Your right to use the work
may be terminated if you fail to comply with these terms.
THE WORK IS PROVIDED “AS IS.” McGRAW-HILL EDUCATION AND ITS LICENSORS MAKE NO
GUARANTEES OR WARRANTIES AS TO THE ACCURACY, ADEQUACY OR COMPLETENESS OF
OR RESULTS TO BE OBTAINED FROM USING THE WORK, INCLUDING ANY INFORMATION
THAT CAN BE ACCESSED THROUGH THE WORK VIA HYPERLINK OR OTHERWISE, AND EX-
PRESSLY DISCLAIM ANY WARRANTY, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED
TO IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE.
McGraw-Hill Education and its licensors do not warrant or guarantee that the functions contained in the work
will meet your requirements or that its operation will be uninterrupted or error free. Neither McGraw-Hill Edu-
cation nor its licensors shall be liable to you or anyone else for any inaccuracy, error or omission, regardless
of cause, in the work or for any damages resulting therefrom. McGraw-Hill Education has no responsibility
for the content of any information accessed through the work. Under no circumstances shall McGraw-Hill
Education and/or its licensors be liable for any indirect, incidental, special, punitive, consequential or similar
damages that result from the use of or inability to use the work, even if any of them has been advised of the
possibility of such damages. This limitation of liability shall apply to any claim or cause whatsoever whether
such claim or cause arises in contract, tort or otherwise.
To my family, I would like to thank my wife, Debbie, and children Alison and Jeff, for their love and
encouragement. And to my parents, I dedicate this book to you in recognition of the unfaltering
support you provided throughout my educational and professional career; I share this latest
accomplishment in your memory.
Contributors...........................................................................xi CHAPTER 8
Preface ...................................................................................xv Prevention of Infective Endocarditis...........................71
Acknowledgements ........................................................ xvii Steven L. Cohn
About the Editor..................................................................xix
SECTION III
SECTION I PREOPERATIVE EVALUATION AND
INTRODUCTION TO PERIOPERATIVE PERIOPERATIVE MANAGEMENT:
PATIENT CARE........................................................1 CO-EXISTING DISEASES AND SPECIAL
POPULATIONS......................................................77
CHAPTER 1
Role of the Perioperative Medical Consultant........... 3 CHAPTER 9
Steven L. Cohn Cardiac Risk Calculators...................................................79
Steven L. Cohn
CHAPTER 2
Preoperative Testing............................................................ 9
CHAPTER 10
Steven L. Cohn and Gerald W. Smetana
Ischemic Heart Disease....................................................85
CHAPTER 3 Steven L. Cohn
Anesthesia for Nonanesthesiologists..........................17
Jeffrey B. Dobyns and Jeffrey W. Simmons CHAPTER 11
Congestive Heart Failure.................................................97
CHAPTER 4 Gregary D. Marhefka and Howard H. Weitz
Perioperative Medication Management....................27
Paul J. Grant and Steven L. Cohn CHAPTER 12
Valvular Heart Disease....................................................103
CHAPTER 5 Gregary D. Marhefka and Howard H. Weitz
Perioperative Management of Anticoagulants������ 43
Scott Kaatz and James D. Douketis CHAPTER 13
Arrhythmias, Conduction System
SECTION II Disorders, and Cardiovascular Implant
PROPHYLAXIS......................................................51 Electronic Devices............................................................111
Nidhi Rohatgi and Paul J. Wang
CHAPTER 6
Prevention of Venous Thromboembolism................53 CHAPTER 14
Smita Kohli Kalra Hypertension.....................................................................121
Efrén Manjarrez
CHAPTER 7
Prevention of Surgical Site Infections.........................63
J. Njeri Wainaina
vii
CHAPTER 15 CHAPTER 26
Pulmonary Disease.........................................................127 Cerebrovascular Disease................................................203
Gerald W. Smetana and Kurt Pfeifer Nidhi Rohatgi
CHAPTER 16 CHAPTER 27
Sleep Apnea and Airway Seizure Disorder, Parkinson’s Disease, and
Management.....................................................................133 Myasthenia Gravis............................................................209
Kurt Pfeifer Nidhi Rohatgi
CHAPTER 17 CHAPTER 28
Pulmonary Hypertension..............................................139 Rheumatoid Arthritis, Lupus, and
Kurt Pfeifer Other Systemic Autoimmune
Diseases...............................................................................219
CHAPTER 18 Linda A. Russell
Diabetes Mellitus..............................................................145
Leonard Feldman CHAPTER 29
The Obese Patient ...........................................................225
CHAPTER 19 Christopher M. Whinney and Sunil K. Sahai
Thyroid Disease.................................................................153
Christopher M. Whinney CHAPTER 30
The Cancer Patient...........................................................233
CHAPTER 20 Sunil K. Sahai
Adrenal Disease (Including
Pheochromocytoma)......................................................161 CHAPTER 31
Christopher M. Whinney and Sunil K. Sahai Surgery and the Older Adult........................................239
Heather E. Nye
CHAPTER 21
Anemia and Transfusion Medicine.............................167 CHAPTER 32
Barbara Slawski Enhanced Recovery Programs.....................................249
Jeffrey W. Simmons and Sunil K. Sahai
CHAPTER 22
Coagulation Disorders ...................................................175 CHAPTER 33
Patrick C. Foy and Kurt Pfeifer Substance Use Disorder.................................................257
Avital Y. O’Glasser
CHAPTER 23
Human Immunodeficiency Virus (HIV).....................185 SECTION IV
J. Njeri Wainaina COMMON POSTOPERATIVE PROBLEMS.......... 265
CHAPTER 24 CHAPTER 34
Chronic Kidney Disease..................................................189 Fever......................................................................................267
Barbara Slawski and Brahm Vasudev J. Njeri Wainaina
CHAPTER 25 CHAPTER 35
Liver Disease......................................................................195 Hypertension and Hypotension.................................271
Avital Y. O’Glasser Efrén Manjarrez
CHAPTER 36 CHAPTER 40
Myocardial Injury after Noncardiac Acute Kidney Injury.........................................................295
Surgery (MINS)..................................................................279 Barbara Slawski and Brahm Vasudev
Steven L. Cohn
CHAPTER 41
CHAPTER 37 Delirium...............................................................................299
Atrial Fibrillation...............................................................283 Heather E. Nye
Nidhi Rohatgi and Paul J. Wang
CHAPTER 42
CHAPTER 38 Pain Management............................................................303
Pneumonia and Respiratory Failure..........................287 Darin J. Correll
Cornelia Taylor
Index.....................................................................................315
CHAPTER 39
Deep Venous Thrombosis and Pulmonary
Embolism............................................................................291
Scott Kaatz
Steven L. Cohn, MD, MACP, SFHM Leonard Feldman, MD, FACP, SFHM, FAAP
Professor Emeritus Program Director
Department of Medicine Combined Internal Medicine-Pediatrics
University of Miami Miller School of Medicine Urban Health Residency Program Director
Miami, Florida Comprehensive General Medicine Consult Service
Chapters 1, 2, 4, 8, 9, 10, 36 Associate Program Director
Osler Medical Residency
Darin J. Correll, MD Associate Professor
Associate Medical Director for Clinical Development Department of Medicine and Pediatrics
Pain Division Johns Hopkins School of Medicine
Vertex Pharmaceuticals Baltimore, Maryland
Boston, Massachusetts Chapter 18
Chapter 42
Patrick C. Foy, MD
Jeffrey B. Dobyns, DO, MSHA, MSHQS, FASA Associate Program Director
Associate Medical Director Hematology–Oncology Fellowship
UAB Perioperative Optimization and Transition Units Assistant Professor
Associate Professor Department of Medicine and Hematology
Department of Anesthesiology Medical College of Wisconsin
University of Alabama Milwaukee, Wisconsin
Tuscaloosa, Alabama Chapter 22
Chapter 3
Paul J. Grant, MD, SFHM, FACP
James D. Douketis, MD, FRCP(C), FACP, FCCP Chief Medical Information Officer
Director Perioperative and Consultative Medicine
Staff Physiciain in Vascular Medicine and General
Associate Professor
Internal Medicine
Department of Medicine
St. Joseph’s Healthcare
University of Michigan
Professor
Ann Arbor, Michigan
Department of Medicine
Chapter 4
McMaster University
Hamiton, Ontario
Chapter 5
xi
Scott Kaatz, DO, MSc, FACP, SFHM Avital Y. O’Glasser, MD, FACP, FHM
Senior Staff Hospitalist Medical Director
Medical Director for Professional Development and Preoperative Medicine Clinic
Research Assistant Program Director
Clinical Professor Social Media and Scholarship
Department of Medicine Associate Professor
Henry Ford Hospital Department of Medicine
Detroit, Michigan Oregon Health and Science University
Chapters 5, 39 Portland, Oregon
Chapters 25, 33
Smita Kohli Kalra, MD, FHM
Associate Professor Kurt Pfeifer, MD, FACP, SFHM
Department of Medicine Chief
University of California Irvine School of Medicine Section of Perioperative and Consultative Medicine
Orange, California Professor
Chapter 6 Department of Medicine
Efrén Manjarrez, MD, SFHM, FACP Medical College of Wisconsin
Milwaukee, Wisconsin
Associate Professor
Chapters 15, 16, 17, 22
Department of Medicine
University of Miami Miller School of Medicine
Nidhi Rohatgi, MD, MS, FACP, SFHM
Miami, Florida
Chapters 14, 35 Chief
Surgical Co-Management Division of Hospital
Gregary D. Marhefka, MD, FACC, FACP Medicine
Program Director Clinical Associate Professor
Cardiovascular Disease Fellowship Department of Medicine
Co-Director Stanford University Medical Center
Cardiovascular Intensive Care Unit Stanford, California
Associate Professor Chapters 13, 26, 27, 37
Department of Medicine and Cardiology
Sidney Kimmel Medical College at Thomas Jefferson Linda A. Russell, MD
University Ann and Joel Ehrenkranz Chair in Perioperative
Philadelphia, Pennsylvania Medicine
Chapters 11, 12 Director of Perioperative Medicine
Director of the Osteoporosis and Metabolic Bone
Heather E. Nye, MD, PhD, SFHM Center
Associate Chief of Medicine Associate Professor of Clinical Medicine
Director Department of Medicine
Co-management and Consult Service Weill Cornell Medical College–Hospital for Special
VA Healthcare System Surgery
Professor New York City, New York
Department of Medicine and Pediatrics Chapter 28
University of California at San Francisco
San Francisco, California
Chapters 31, 41
Worldwide, over 200 million people undergo major bridging, should surgery be delayed for a sleep study,
surgery every year. Although patients are unlikely to and many more. They also repeatedly requested lists
die from anesthesia, the burden of perioperative com- of risk factors, tables for medication management, and
plications falls more on exacerbations of underlying algorithms for the approach to evaluation and man-
medical conditions, in part because we are operating agement of various comorbid conditions. This book is
on older and sicker patients. While it is unrealistic to a response to these requests. I invited leading experts
believe that perioperative deaths and complications to distill their vast knowledge and experience into
can be completely eliminated, our goal is to minimize focused, need-to-know information that will be use-
this risk as much as possible. ful to clinicians at the point-of-care. Over two-thirds
With the explosion of medical knowledge, treat- of the book contributors are senior faculty members
ment innovation, and increasing specialization, it is with professor or associate professor appointments
difficult for any physician to keep current with the and serve as section chiefs and perioperative clinic
constant influx of information. While surgeons, anes- or service directors. The result is this practical deci-
thesiologists, and some hospitalists may spend a major sion-making reference which incorporates infor-
portion of their clinical time caring for patients in the mation from multiple guidelines, clinical trials, and
perioperative period, many other hospitalists, pri- expert opinion. It uses algorithms, tables, and clinical
mary care physicians, and their teams of nurse prac- pearls to summarize the key concepts and takeaways.
titioners and physicians assistants may need guidance Our collective goal is to navigate clinicians to the
to address specific issues for their patients before and/ best evidence-based and most cost-effective decisions
or after surgery. The goal of this book is to provide that will in turn ensure quality, patient-safety, and
a simple, direct guide to the medical, as opposed to optimal perioperative outcomes. To this end, the con-
surgical and anesthetic, aspects of perioperative care. tent has been organized into four sections:
It is not intended to be a comprehensive textbook, and
references have deliberately been limited to keep the
1. key takeaways on perioperative evaluation, test-
focus on the practical aspects of patient care. This
ing, anesthesia, and medication management;
book is intended for use by all members of the periop-
2. prophylaxis to prevent venous thromboembolism,
erative team - hospitalists, general internists and spe-
surgical site infection, and endocarditis;
cialists, anesthesiologists, surgeons, advanced practice
3. guidance on specific risk factors by organ system
providers, and residents in-training who are caring for
to help clinicians evaluate the effect of various
patients before and after surgery.
comorbidities on surgical outcome and provide
The genesis of this book comes from a lecture I
perioperative management to minimize risk; and
gave at the annual meeting of the American Col-
4. a brief review of common postoperative medical
lege of Physicians. Attendees at the session asked
complications and their treatment.
many questions - which risk calculator should I use,
how long should surgery be delayed after percutane-
ous coronary intervention (PCI), should aspirin be The field of perioperative medicine continues to
continued, how long before surgery should I stop a evolve, and new information may make previous
direct-acting oral anticoagulant (DOAC), who needs guidelines and recommendations obsolete. Errors,
xv
inaccuracies, and omissions are an inevitable part testing of patients who have had COVID-19. Due to
of any human endeavor, and the reader is urged to this lack of information and the evolving nature of the
use this book in the context of clinical judgment and problem, I have chosen not to include a chapter on
confirm information, particularly as it relates to med- this topic.
ications and dosing. This book was written during a With over 30 years of experience in perioperative
difficult time – the COVID-19 pandemic. We have medicine and having served as the director of preop-
not witnessed anything like this in the modern era. erative clinics and medical consultation services at two
At the time this book was going to press, over 2,100,000 major academic medical centers (SUNY Downstate
lives have been lost worldwide (over 425,000 in the Medical Center/Kings County Hospital and University
U.S. alone), and the numbers continue to increase. of Miami Miller School of Medicine/Jackson Memo-
It has burdened our health system and changed sur- rial Hospital), I have dedicated my medical career to
gical practice. The coronavirus affects multiple organ the field of perioperative medicine. I hope that this
systems, and we do not fully know the extent of its book will provide key information to increase knowl-
after-effects. Scheduling and operating room proce- edge and instill confidence in clinicians p roviding
dures have changed and continue to evolve, guided by perioperative care, and as a result help ensure optimal
recommendations from various societies, and periop- patient outcomes.
erative testing for COVID-19 varies by hospital and
test availability. There are currently no specific guide- –Steven L. Cohn, MD, MACP, SFHM
lines for any changes to perioperative evaluation and
I would like to acknowledge James Shanahan from McGraw Hill and Diane Scott-Lichter from ACP for inviting
me to edit this book, and Kay Conerly and Christie Naglieri for their advice and support in keeping this project
on track. Special thanks to Dr. Robert Lavender, Professor of Medicine at the University of Arkansas for his
review of and critical feedback on the entire manuscript. I would also like to thank all of the contributors for
their chapters and ability to stick to the deadlines despite the COVID-19 pandemic.
xvii
Dr. Cohn is Professor Emeritus in the Department of Medicine at the University of Miami Miller School of
Medicine. He is the former Director of the Medical Consultation Service at Jackson Memorial Hospital and
Medical Director of the UHealth P reoperative Assessment Center (UPAC) and M edical Consultation Service
at the University of Miami Hospital, having relocated to Miami after 30 years at the State University of New
York - Downstate Medical Center in Brooklyn. He served as the Chief of the Division of General Internal
Medicine and Associate Medical Director for Performance Improvement at Downstate, and the Director of the
Preoperative Medical Consultation Clinic and Medical Consultation Service at Kings County Hospital Center.
He was responsible for education and supervision of over 1000 senior medical residents in both inpatient and
ambulatory care settings, and he has evaluated over 30,000 patients preoperatively. After receiving his medical
degree from the University of Monterrey, Dr. Cohn completed his residency in internal medicine at SUNY-
Downstate Medical Center. He is a Master of the American C ollege of Physicians (ACP), a senior fellow of the
Society for Hospital Medicine (SHM), and a board member of the Society for Perioperative Assessment and
Quality Improvement (SPAQI). He has given over 400 lectures, authored/edited three books and over 100 book
chapters and peer-reviewed manuscripts, and in 2017, he received the Society for Hospital Medicine award for
Excellence in Teaching.
xix
TABLE 1-1. Original and Modified Ten Commandments for Effective Consultations
1983 2006
COMMANDMENTS1 MODIFICATIONS2 MEANING AND MODIFICATION
1 Determine the Determine your customer. If the specific question is not obvious, call the
question. requesting physician – and ask if they want
comanagement.
3 Look for yourself. Look for yourself. Gather data independently to be most effective.
4 Be brief as Be brief as appropriate. No need to repeat in full detail the data that were
appropriate. already documented.
7 Thou shalt not covet Thou may negotiate In most cases, consultants should play a subsidiary
thy neighbor’s turf. joint title to thy role; however, consultants can and should co manage
neighbor’s turf. any facet of patient care the requesting physician
desires (but clarify who is responsible for what).
8 Teach with tact. Teach with tact and Sharing your expertise is appreciated – although
pragmatism. decisions on leaving references should be tailored to the
requesting physician’s specialty, level of training, and
urgency of the consult.
9 Talk is cheap and Talk is essential. There is no substitute for direct personal contact with
effective. the primary physician.
10 Provide appropriate Follow-up daily. Recognize when to fade into a background role, but
follow-up. that time is almost never on the same day as the
consult. Daily written follow-up notes are desirable,
but when problems are no longer active, sign-off after
discussing with the requesting physician.
Data from Salerno et al. Arch Intern Med. 2007; 167:271-275 and Goldman et al. Arch Intern Med. 1983;143(9):1753-1755.
the specific problem rather than other medical issues, the consultant and the surgical team need to be clearly
follows-up briefly in the postoperative period, and defined in advance. Another type of consultation is
then signs off. More recently, many surgeons are the so-called “curbside” or informal consult in which
requesting the medical consultant to assume more of the consultant is asked to provide an opinion or advice
a co management role taking a more global approach, without personally seeing the patient. These should be
addressing all necessary medical issues, writing orders, discouraged from a medicolegal standpoint as there
and providing daily follow-up. The responsibilities of is no formal doctor–patient relationship although at
times this has been challenged in court. Instead, the Answering the Question
consultant should offer to perform a formal consult,
In order to decide whether the patient is medically
but if any advice is given, it should be generic and sim-
optimized for surgery, the consultant must identify
ple. The “consultant” should also inform the request-
and address any specific medical problem mentioned
ing physician not to refer to him in the medical record.
as well as any others that may impact surgical risk.
As noted above, there has been a shift from the tra-
Determining the Question
ditional consult to more of a comanagement request,
Although incumbent on the requesting physician and the consultant now tends to address more than
to clearly define the reason for the consultation just the specific disease that was initially mentioned.
and provide relevant information, this is often not The basic approach on how to answer the question
the case. Many consult requests only state “med- is listed in Table 1-2. The consultant should also
ical clearance” or “preoperative evaluation” with- avoid use of the phrase “cleared for surgery,” even
out mentioning the medical problems or even the if that was the request, as it implies that the proce-
type of surgery planned. Therefore, it is impera- dure carries no risk for the particular patient when
tive for the consultant to determine what is being all patients are potentially at some risk when they
requested to be able to respond appropriately. undergo anesthesia and surgery. The consultant can-
The best way to clarify the question is by direct verbal not and should not guarantee a complication-free
communication with the requesting physician. outcome.
4) Does it affect surgical risk? Decide if this disease has an important impact on risk
and whether it requires treatment now.
5) Are additional tests indicated to improve risk Ascertain what other information, if any, will affect
estimation or change management? clinical decision-making.
6) Are there treatments that will reduce risk? Determine what treatments are available that might
lower risk of perioperative complications without
potential for harm.
8) Should surgery be postponed for further workup Assess whether the patient is medically optimized or
and treatment? would benefit in terms of lower risk by additional
workup or therapy now as opposed to after surgery.
9) What do the surgeon and anesthesiologist think? Communicate with your colleagues and get their input.
10) What do the patient and family want? Discuss risks/benefits with the patient/family to involve
them in decision-making.
Pertinent medical problems Cardiopulmonary disease, HTN, DM, thyroid disease, bleeding disorder, stroke,
(positive or negative) seizures
Social history Tobacco, alcohol, drug use – amount, duration, last use
Pertinent family history Genetically related diseases: malignant hyperthermia, bleeding disorders
Review of systems (focused) Cardiopulmonary (chest pain, dyspnea, cough), exercise capacity/ADLs,
bleeding/bruising
Physical exam Vital signs, usual exam with focus on airway, dentition, murmur/gallop,
adventitious sounds, neurologic deficit, mental status/cognitive dysfunction
Lab tests Patient and surgery directed testing (pertinent basic blood tests, ECG) and any
specific results of relevant recent/past cardiac tests (stress test, echocardiogram,
coronary angiography, pacemaker interrogation), PFTs, head CT/MRI, carotid
dopplers, etc.
Impression Patient is/is not in his/her optimal medical condition (or is medically optimized)
for the planned procedure
Recommendations Current meds (continue, stop, change dose), new meds, prophylaxis (SSI, VTE, IE),
postop monitoring (ECG, troponin, telemetry, pulse oximetry)
Consultant information Name, contact info (cellphone/beeper); date/time consult report was written
DOB-date of birth; MR-medical record; HTN-hypertension; DM-diabetes mellitus; Rx-prescription; OTC-over the counter; ADL-
activities of daily living; ECG-electrocardiogram; PFT-pulmonary function test; CT-computerized tomography; MRI-magnetic reso-
nance imaging; SSI-surgical site infection; VTE-venous thromboembolism; IE-infective endocarditis; OSA-obstructive sleep apnea
TABLE 1-4. Factors that Influence or Improve (immediate phone contact followed by in-person eval-
Compliance with Consultant Recommendations uation within 10–30 minutes or less). Be concise, prior-
itize crucial recommendations, and limit the number
Prompt response (within 24 hours)
of recommendations. The longer the list, the less
Limit number of recommendations (≤ 5) likely all recommendations will be addressed. The
more severely ill the patient, the more likely recom-
Identify crucial or critical recommendations mendations will be implemented. Recommendations
(vs. routine) regarding therapy are somewhat more likely to be
Focus on central issues followed than those for diagnostic tests. Use defin-
itive language and be specific, particularly when
Make specific relevant recommendations recommending medications. Specify the drug (not
Use definitive language
class), dose, frequency, route of administration, and
duration of therapy as the surgeon may not be famil-
Specify drug dosage, route, frequency, duration iar with the medication. Although some EMRs may
automatically notify the requesting physician when
Frequent follow-up including progress notes
a consult has been completed, and the current gen-
Direct verbal contact eration of clinicians tends to rely on text messaging
rather talking, direct verbal communication with the
Therapeutic (versus diagnostic) recommendations surgeon is the most-effective means of discussing
Severity of illness your thoughts and recommendations. A preliminary
text can be sent, but it should be quickly followed by
Reproduced with permission from: Cohn SL. Overview of a phone call to ensure that the message was received
the principles of medical consultation and perioperative
medicine. In: UpToDate, Post TW (Ed), UpToDate, Waltham,
and that there are no questions regarding patient man-
MA. (Accessed on June 15, 2020.) Copyright © 2020 UpToDate, agement. Make appropriate follow-up visits to ensure
Inc. For more information visit www.uptodate.com. that recommendations were followed and reassess the
patient, and document your findings in a progress
note. Depending on the situation, follow-up may be
as short as a single postoperative visit, or in the case of
addresses the question being asked, assesses medical a severely ill patient or co management, may be daily
optimization and surgical risk, and makes recommen- until improvement or discharge. When signing off,
dations for perioperative management. Table 1-3 is document this in the medical record and inform the
a checklist for items to be included in the consultation surgical team. Also, indicate if the patient requires any
report. specific follow-up after discharge.
REFERENCES
1. Goldman L, Lee T, Rudd P. Ten commandments for
effective consultations. Arch Intern Med. 1983;143(9):
1753-1755.
TABLE 2-1. Choosing Wisely Campaign. Society Recommendations to Limit Preoperative Testing
SOCIETY RECOMMENDATION
American Society of Hematology- Don’t perform routine preoperative hemostatic testing (PT, aPTT) in
American Society of Pediatric an otherwise healthy child with no prior personal or family history of
Hematology/Oncology bleeding.
American Society of Anesthesiologists Don’t obtain baseline laboratory studies in patients without significant
systemic disease (ASA I or II) undergoing low-risk surgery – specifically
complete blood count, basic or comprehensive metabolic panel,
coagulation studies when blood loss (or fluid shifts) is/are expected to
be minimal.
Society of General Internal Medicine Don’t perform routine preoperative testing before low-risk surgical
procedures.
American College of Surgeons Avoid admission or preoperative chest x-rays for ambulatory patients
with unremarkable history and physical exam.
American Academy of Ophthalmology Don’t perform preoperative medical tests for eye surgery unless there
are specific medical indications.
The Society of Thoracic Surgeons Prior to cardiac surgery, there is no need for pulmonary function testing
in the absence of respiratory symptoms.
The Society of Thoracic Surgeons Patients who have no cardiac history and good functional status do not
require preoperative stress testing prior to noncardiac thoracic surgery.
Society of Cardiovascular Computed Don’t order coronary artery calcium scoring for preoperative evaluation
Tomography for any surgery, irrespective of patient risk.
American Society for Clinical Avoid routine preoperative testing for low-risk surgeries without a
Pathology clinical indication.
American College of Radiology Avoid admission or preoperative chest x-rays for ambulatory patients
with unremarkable history and physical exam.
American College of Physicians Don’t obtain preoperative chest radiography in the absence of a clinical
suspicion for intrathoracic pathology.
Adapted with permission from: Meyer TE. Perioperative management of heart failure in patients undergoing noncardiac surgery.
In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. (Accessed on January 27, 2020.) Copyright © 2020 UpToDate, Inc. For more
information visit www.uptodate.com.
TABLE 2-2. The Incidence of Abnormal Preoperative Tests That Change Management and the Change in the
Likelihood of Postoperative Complications Based on the Test Results
TEST INCIDENCE OF ABNORMALITIES THAT LR + LR-
INFLUENCE MANAGEMENT (%)
Adapted from: Smetana GW, Macpherson DS. The case against routine preoperative laboratory testing. Med Clin Am 2003;87:7-40
with permission from Elsevier.
complications could be identified through a careful his- anemia itself increases mortality, or if it is a marker for
tory and physical examination. The incidence of abnor- underlying comorbidities (see Chapter 21) (Table 2-3).
malities that changed management ranged from 0% to In general, a platelet count adds little if there is no
3%, depending on the test (Table 2-2). clinical history of bleeding tendency. It is rare for clini-
cally significant thrombocytopenia (< 50,000) to exist
SPECIFIC TESTS in the absence of a clinical history of bleeding ten-
dency or a chronic medical condition that can cause
Complete Blood Count thrombocytopenia. We suggest this test for patients
For patients undergoing surgery with a large amount undergoing neuraxial anesthesia and those under-
of anticipated blood loss, it is reasonable to perform a going intracranial neurosurgery. A white blood cell
CBC, which includes measurement of hemoglobin and count does not predict infectious or other periopera-
hematocrit, before surgery. This will guide discussions tive complications. However, since both are elements
with the patient about a potential need for perioper- of a CBC, which is an inexpensive test, it is reasonable
ative transfusions. For low-risk surgery, or high-risk to perform a full CBC if there is an indication for mea-
surgery with little anticipated blood loss, a preoperative suring hemoglobin or hematocrit before surgery.
CBC is not necessary. It is also reasonable for patients
Measurement of Renal Function and Electrolytes
over 65 years old who are undergoing major surgery.
While preoperative anemia confers a higher risk of Perioperative chronic kidney disease may influence
postoperative mortality than for patients with nor- anesthetic management and prompt more careful or
mal hemoglobin and hematocrit, it is unknown if the frequent monitoring of renal function after surgery.
TABLE 2-3. Indications for Commonly Ordered Preoperative chronic kidney disease (serum creatinine
Preoperative Tests > 2.0 mg/dl) is also one of six independent risk factors
for postoperative cardiac complications in the widely
TEST INDICATIONS*
used revised cardiac risk index (RCRI).4 Preoperative
Hemoglobin Symptoms of anemia, major blood measurement of renal function (primarily serum cre-
loss surgery atinine) should be performed selectively, rather than
in all patients undergoing surgery. Abnormalities are
WBC Infection, myeloproliferative uncommon in patients with no medical conditions
disease, myelotoxic meds
or medication use for which chronic kidney disease
Platelets Abnormal hemostasis, is possible. For example, it is appropriate to check
chemotherapy or renal function before major surgery in patients with
medications associated with diabetes, congestive heart failure, or known chronic
thrombocytopenia kidney disease. It is reasonable to measure in patients
over age 50 years old undergoing major surgery, as the
PT/INR History of bleeding diathesis, liver
disease, malnutrition, antibiotics, prevalence of chronic kidney disease increases with
warfarin age. Preoperative renal function testing is also recom-
mended for patients who are taking medications that
PTT History of bleeding diathesis may affect renal function. This would include ACE
Electrolytes CKD, HF, diarrhea, medications inhibitors, ARBs, diuretics, and NSAIDs.
that increase risk of electrolyte A theoretical reason for measuring electrolytes
abnormalities (ACEI/ARB, diuretic) would be to identify patients who may require potas-
sium supplementation after surgery or to predict the
BUN/ CKD, HTN, cardiac disease, elderly, potential for arrhythmia. The indication for measur-
creatinine meds ing preoperative electrolytes is like those noted above
Glucose DM (history or suspected); obesity, for measurement of renal function. In particular, pre-
steroids operative measurement of electrolytes is appropriate
for patients undergoing major surgery who are taking
LFTs Hepatitis (acute); cirrhosis one of the above medications. Neither preoperative
U/A GU instrumentation renal function nor electrolytes should be measured
routinely.
Pregnancy Woman of childbearing age,
test particularly if possibility of
pregnancy cannot be excluded Glucose
by history Hyperglycemia has been associated with an increase in
ECG Known/suspected cardiac disease, postoperative complications. While routine screening
intermediate-high risk surgery for all patients is not recommended, a serum glucose
is indicated for patients with known DM to assess cur-
CXR Active/suspected pulmonary rent control, and those with signs and symptoms sug-
disease gestive of DM for diagnostic purposes. Other potential
WBC-white blood cell; PT-prothrombin time; INR- indications include corticosteroid use and obesity,
International Normalized Ratio; PTT-partial thromboplastin both of which may be associated with hyperglycemia.
time; BUN-blood urea nitrogen; LFT-liver function tests; Although perioperative glucose levels correlate
U/A-urinalysis; ECG-electrocardiogram; CXR-chest x-ray; better than HbA1C levels for perioperative compli-
CKD-chronic kidney disease; HF-heart failure; ACEI/ARB-
angiotensin converting enzyme inhibitor/angiotensin
cations, the ADA recommends obtaining HbA1C in
receptor blocker; HTN-hypertension; DM-diabetes mellitus; hospitalized patients with DM and those with hyper-
GU-genitourinary glycemia (glucose >140 mg/dl) if not done in the past
3 months.5 Because the HbA1C level correlates with The ASA Task Force on Preanesthesia Evaluation
the average glucose during the past 3 months, serum Practice Advisory recommends against routine testing
fructosamine level may be a better measure of recent and suggests selective ordering of coagulation tests
glucose control as it reflects the average over the past based on history of bleeding disorders, renal dysfunc-
2–3 weeks. (See chapter on DM.) tion, liver dysfunction, type and invasiveness of pro-
cedure, and medications.2 The NICE guidelines also
Liver Function Tests recommend against routine preoperative hemostasis
tests but to consider them in people with chronic liver
In general, these tests should only be obtained in
disease undergoing intermediate, major, or complex
patients with suspected acute hepatitis (viral, alcoholic,
surgery or in those taking anticoagulants.7
or drug-induced), as elective surgery is contraindicated
in this setting, or as needed to evaluate patients with
Urinalysis
cirrhosis using the Child Pugh or MELD scores (albu-
min, bilirubin). Otherwise, liver function tests should The theory behind ordering a routine urinalysis before
not be performed preoperatively. (See chapter on liver surgery is to identify and treat asymptomatic bacteri-
disease.) uria (urinary tract infection or colonization), thereby
reducing the risk of perioperative infections. Most
Coagulation Tests studies on routine urinalyses have involved orthope-
dic patients undergoing total joint arthroplasty with
Standard coagulation tests such as the prothrombin
the objective being to prevent a prosthetic joint infec-
time/international normalized ratio (PT/INR) and
tion. However, the evidence has not shown a benefit
partial thromboplastin time (PTT) are frequently
for these patients. Although patients with asymptom-
obtained preoperatively to assess coagulopathy and
atic bacteriuria may have a higher incidence of pros-
guide therapy. However, the preponderance of evi-
thetic joint infection, there was no difference between
dence from multiple studies suggests that these
those treated with antibiotics and those who were
screening tests are not useful in predicting periopera-
not treated, suggesting that asymptomatic bacteriuria
tive bleeding in patients without known bleeding risk
may be a marker for risk of infection rather than the
factors. Furthermore, abnormal results often lead to
cause. Furthermore, the pathogens in the joint infec-
additional testing and possible delays in planned sur-
tions did not match those organisms isolated in the
gery. The PT/INR and PTT were designed to moni-
urine culture. The International Consensus Meeting
tor the anticoagulant effects of warfarin and heparin
on Periprosthetic Joint Infection recommended not
and to assess coagulation factor deficiencies – not to
to order routine urinalyses before total joint replace-
predict bleeding or guide hemostatic therapy.
ments although this is still a commonly encountered
Taking an accurate bleeding history, which inclu
practice.8 In addition, guidelines from the Infectious
des medications that might affect hemostasis and the
Disease Society of America recommend against
patient’s personal and family bleeding history, will
screening for or treating asymptomatic bacteriuria in
detect most significant bleeding disorders and is more
patients undergoing elective nonurologic procedures
important than unselected blood testing (see chapter
(strong recommendation, low-quality evidence).9 On
on Coagulation Disorders). Most adult patients with
the other hand, in patients who will undergo endo-
hemophilia will have already been diagnosed, and
scopic urologic procedures associated with mucosal
patients with von Willebrand’s disease may also be
trauma, we recommend screening for and treating
more likely to be identified by history as PTT alone
asymptomatic bacteriuria prior to surgery (strong
will not necessarily be abnormal. Although bleeding
recommendation, moderate-quality evidence).
in certain situations like neurosurgery could be cata-
strophic, a large study in this patient population also
Urine Pregnancy Test
found that bleeding history was more predictive of
bleeding complications (need for transfusion, return Routine preoperative pregnancy testing is controver-
to the operating room, or 30-day mortality) than sial, although it is commonly required for all women
routine blood tests.6 of reproductive age before anesthesia. Pregnancy can
be excluded either by history, using a WHO check- with risk factors scheduled for intermediate or high-
list,10 or by testing. The provider can be reasonably risk surgery. However, they also state to consider a pre-
certain that the woman is not pregnant (>99% nega- operative ECG in patients with a risk factor undergoing
tive predictive value) if she has no symptoms or signs low-risk surgery or with no risk factors if above 65 years
of pregnancy and meets any of the following criteria: of age and undergoing intermediate-risk surgery.11
1) She has not had intercourse since last normal men- The National Institute for Health and Care Excellence
ses. 2) She has been correctly and consistently using (NICE) Guideline Development Group (GDG) also
a reliable method of contraception. 3) She is within said to consider a resting ECG in ASA 1 patients over
the first 7 days after normal menses. 4) She is within 65 undergoing major or complex surgery if there were
4 weeks postpartum (for nonlactating women). 5) She no previous ECG results available from the past year.7
is within the first 7 days postabortion or miscarriage. The 2007 ACC/AHA guidelines did not recommend a
or 6) She is fully or nearly fully breastfeeding, amenor- preoperative ECG based on age alone, required at least
rhoeic, and less than six months postpartum. one clinical risk factor (except for vascular surgery),
The ASA guidelines recommend offering preg- and recommended against an ECG in asymptomatic
nancy testing to women in whom pregnancy is pos- patients for low-risk surgeries.12 However, the 2014
sible.2 In some institutions, rather than being a true ACC/AHA guidelines changed to a more liberal posi-
requirement, women have the option to refuse testing tion basically suggesting that an ECG could be obtained
after having a discussion regarding the risks associated in any asymptomatic patient even without heart disease
with anesthesia, surgery, and pregnancy. If she refuses, except for those undergoing low-risk surgery, but did
it is important to document this process in the medi- note that a standard age or risk factor cutoff for use of
cal record. Although the incidence of a positive test is preoperative testing has not been defined.13 The ASA
low, it typically results in cancellation of surgery. Since Task Force recognized that age alone may not be an
most preoperative testing is done days to weeks prior indication for an ECG and stated that cardiovascular
to surgery, routine screening for pregnancy is typically risk factors may be an indication for ECG.2
done on the day of surgery. Another reason given for obtaining a preoperative
ECG is to have a baseline for comparison postoper-
Electrocardiogram atively if needed. However, this is not as helpful as
troponin in making the diagnosis of a postoperative
Although electrocardiographic abnormalities are
myocardial infarction.
often associated with postoperative cardiac complica-
We recommend obtaining a preoperative ECG if
tions, they typically do not provide additional infor-
the history suggests cardiac disease or if the patient is
mation beyond that obtained from the history and
undergoing vascular and possibly other high-risk sur-
physical exam. Multiple abnormalities identified to
gery. It is not indicated for patients undergoing low-
have prognostic significance, although with poor con-
risk surgery or based purely on age.
cordance across various studies, include arrhythmias,
pathological Q-waves, left ventricular hypertrophy,
Chest X-rays
ST depression, QTc prolongation, and bundle branch
blocks. Some of these are detectable on physical exam, Abnormal findings on a preoperative chest x-ray are
and most do not usually result in any change in man- rarely unexpected. For example, x-ray findings of
agement and almost never alter outcomes. The most COPD or CHF would not usually escape detection
important ECG finding which is rarely encountered by a careful history and physical examination. Studies
would be evidence of a silent myocardial infarction have suggested that approximately 1% of preoperative
(pathological Q waves) that was not present on a pre- chest x-rays yield results that are unexpected, and even
vious ECG done in the past 2 months. fewer change management. In addition, these findings
Electrocardiographic abnormalities increase with do not necessarily predict postoperative pulmonary
age; therefore, this has often been used as a criterion to complication rates more accurately than clinical eval-
obtain a baseline preoperative electrocardiogram. The uation. So once again, this test should be performed
2014 ESC guidelines recommend an ECG for patients selectively.
Certain incidental findings may occasionally 3. Benarroch-Gumpel J, Sheffield KM, Duncan CB, et al.
prompt further elective outpatient evaluation, such Preoperative laboratory testing in patients undergo-
as a solitary nodule. However, the recommendations ing low-risk ambulatory surgery. Ann Surg. 2012;256:
for screening for such conditions do not differ in the 518-522.
4. Lee TH, Marcantonio E, Mangione CM, et al. Derivation
perioperative period. Another rationale is to provide
and prospective validation of a simple index for pre-
a baseline in the event that a postoperative chest x-ray
diction of cardiac risk of major noncardiac surgery.
is required for a clinical indication. However, poten- Circulation. 1999;100:1043-1049.
tial findings of pneumonia or CHF can easily be diag- 5. American Diabetes A. 15. Diabetes Care in the Hospital:
nosed without the benefit of a preoperative baseline. Standards of Medical Care in Diabetes-2020. Diabetes
The American College of Physicians recommended Care. 2020;43(suppl 1):S193-S202.
a preoperative chest x-ray for patients over 50 years 6. Seicean A, Schiltz NK, Seicean S, Alan N, Neuhauser
old undergoing major surgery, and those with under- D, Weil RJ. Use and utility of preoperative hemostatic
lying cardiopulmonary disease.14 This is largely expert screening and patient history in adult neurosurgical
opinion as opposed to strongly evidence-based and patients. J Neurosurg. 2012;116:1097‐1105.
is now somewhat outdated. The American Society 7. O’Neill F, Carter E, Pink N, Smith I. Routine preopera-
tive tests for elective surgery: summary of updated NICE
of Anesthesiologists observes similar risk factors but
guidance. BMJ. 2016;354:i3292. Available at https://www.
does not feel that these are unequivocal indications for
nice.org.uk/guidance/ng45/chapter/Recommendations.
a preoperative chest x-ray.2 These risk factors include 8. Proceedings of the International Consensus Meeting
smoking, recent upper respiratory tract infection, on Periprosthetic Joint Infection. Gehrke T, Parvizi J.
COPD, cardiac disease, and advanced age. 2013. Available at https://rothmanortho.com/stories/
blog/rothman-jefferson-philadelphia-internation-
Clinical pearls al-joint-consensus. Accessed June 4, 2020.
■■ Preoperative testing is NOT indicated when
9. Nicolle LE, Gupta K, Bradley SF, et al. Clinical Practice
Guideline for the Management of Asymptomatic
used as screening/routine testing or for mini-
Bacteriuria: 2019 Update by the Infectious Diseases
mally invasive surgeries or procedures.
Society of America. Clinical Infectious Diseases.
■■ Do not repeat tests when recent studies were 2019;68:e83e110. Available at https://doi.org/10.1093/
done within the past 6 months, and results are cid/ciy1121.
unlikely to have changed. 10. World Health Organization. Selected Practice
Recommendations for Contraceptive Use. 3rd ed. World
■■ Preoperative testing IS indicated when done
Health Organization; 2016. Available at https://apps.
selectively based on a targeted history and phys-
who.int/iris/handle/10665/252267.
ical or for higher-risk surgical procedures in 11. Kristensen SD, Knuuti J, Saraste A, et al. 2014 ESC/
higher-risk patients. ESA Guidelines on non-cardiac surgery: cardiovascu-
■■ Age alone should not be criteria to order a test. lar assessment and management: The Joint Task Force
on non-cardiac surgery: cardiovascular assessment and
■■ Do NOT order preoperative tests IF the results
management of the European Society of Cardiology
will NOT influence management.
(ESC) and the European Society of Anaesthesiology
(ESA). Eur Heart J. 2014;35(35):2383‐2431.
12. Fleisher LA, Beckman JA, Brown KA, et al. ACC/
REFERENCES AHA 2007 guidelines on perioperative cardiovascular
1. Choosing Wisely Campaign. “Search on: preoperative.” evaluation and care for noncardiac surgery: a report
Available at https://www.choosingwisely.org/. Accessed of the American College of Cardiology/American
January 27, 2020. Heart Association Task Force on Practice Guidelines
2. Committee on Standards and Practice Parameters, (Writing Committee to Revise the 2002 Guidelines
Apfelbaum JL, Connis RT, et al. Practice advisory for on Perioperative Cardiovascular Evaluation for
preanesthesia evaluation: an updated report by the Noncardiac Surgery) developed in collaboration with
American Society of Anesthesiologists Task Force on the American Society of Echocardiography, American
Preanesthesia Evaluation. Anesthesiology. 2012;116(3): Society of Nuclear Cardiology, Heart Rhythm Society,
522‐538. Society of Cardiovascular Anesthesiologists, Society
INTRODUCTION: BEYOND first two goals are accomplished in the weeks before
PHARMACOLOGY AND PHYSIOLOGY surgery to allow for intervention. Optimization for
surgery includes patient education on the risks, bene-
Anesthesia is an interplay between pharmacology fits, and alternatives to surgery and anesthetic options.
and physiology. Medications used during anesthesia Three, develop a patient-specific anesthetic plan based
provide a specific function of a balanced anesthetic on the type of surgery and comorbidities. The day of
technique comprised of amnesia, analgesia, akinesia, surgery anesthesia care team determines the final anes-
hypnosis, and control of autonomic responses. The thetic plan, including drug choice and dosing sequence,
anesthesiologist directs this biological interaction level of sedation required, definitive airway manage-
while also playing a vital leadership role in the periop- ment, and communication with the surgery team.
erative team. This physician leads a team of nurse The anesthesia and surgical teams often solicit
anesthetists, anesthesia assistants, or residents, engages input from primary care or specialty medicine ser-
with hospital consults to develop a safe anesthetic plan, vices, such as cardiology or pulmonology, to aid in
communicates risks and plans with the surgery team, preoperative risk stratification. The purpose of this
and directs intraoperative and perioperative care. Most consultation is to assess the opportunity for optimiza-
importantly, the anesthesiologist will explain the anes- tion of chronic medical conditions that have a direct
thesia-related risks, benefits, and alternatives with the bearing on surgical and anesthetic outcomes.
patient with the goal of shared decision-making. Surgical clearance is an older term that implies a
degree of certainty of outcome. It does not address
perioperative care, risk factor modification, or coordi-
PREOPERATIVE EVALUATION
nation of care issues, and is not focused on longitudi-
The overall goal of preoperative evaluation for anes- nal health improvement and management. Clearance
thesiologists is threefold. One, identify modifiable often leaves patients feeling as though there is “zero
risks that are amenable to optimization before surgery risk” to them from their anesthetic and surgical pro-
and create a plan of action to address or improve the cedure. Writing “cleared for surgery” has no meaning
comorbidity in an attempt to improve overall patient to the surgery and anesthesia teams as there is no indi-
outcomes. Two, risk stratify the patient based on a cation of the basis of the clearance. Equally less useful
thorough assessment to determine the need for addi- are the common recommendations to “avoid hypoxia,
tional cardiopulmonary testing, delay in the procedure, hypotension, and hypothermia,” since avoidance of
or move to an appropriate surgical location. Ideally, the these factors is fundamental to all anesthetics.
17
ASA II A patient with mild Mild diseases only without substantive functional limitations.
systemic disease Examples include (but not limited to): current smoker, social
alcohol drinker, pregnancy, obesity (30 < BMI < 40), well-
controlled DM/HTN, mild lung disease
ASA III A patient with severe Substantive functional limitations; one or more moderate to severe
systemic disease diseases. Examples include (but not limited to): poorly controlled
DM or HTN, COPD, morbid obesity (BMI ≥40), active hepatitis,
alcohol dependence or abuse, implanted pacemaker, moderate
reduction of ejection fraction, ESRD undergoing regularly
scheduled dialysis, premature infant PCA < 60 weeks, history
(>3 months) of MI, CVA, TIA, or CAD/stents.
ASA IV A patient with severe Examples include (but not limited to): recent ( < 3 months) MI,
systemic disease that CVA, TIA, or CAD/stents, ongoing cardiac ischemia or severe valve
is a constant threat dysfunction, severe reduction of ejection fraction, sepsis, DIC, ARD
to life or ESRD not undergoing regularly scheduled dialysis
ASA V A moribund patient Examples include (but not limited to): ruptured abdominal/thoracic
who is not expected aneurysm, massive trauma, intracranial bleed with mass effect,
to survive without the ischemic bowel in the face of significant cardiac pathology or
operation multiple organs/system dysfunction
ASA VI A declared brain-dead *The addition of “E” denotes Emergency surgery: (An emergency is
patient whose organs defined as existing when delay in treatment of the patient would lead
are being removed for to a significant increase in the threat to life or body part)
donor purposes
Ketamine. Ketamine is a rapidly acting anesthetic plan and generally have minimal hemodynamic effects.
agent administered intravenously or intramuscularly. Opioid administration is associated with postoperative
In addition to its hypnotic and analgesic effects, ket- and postdischarge nausea and vomiting. Opioid-sparing
amine has minimal cardiovascular depressant effects. techniques of pain management, standard in enhanced
In-situ, ketamine may increase heart rate and cardiac recovery pathways, employ regional techniques (nerve
output, making it an ideal medication in trauma anes- blockade), or multimodal adjuncts (acetaminophen,
thesia and has been used as a battlefield anesthetic NSAIDs, GABA inhibitors) instead of opioids.
by the military for many years. Ketamine’s hypnotic
action works through blocking NMDA receptors, Amnesia
while its analgesic actions may have cholinergic, ami-
Amnesia in anesthesiology is a medication-induced
nergic, and opioid system properties.
short-term loss of memory surrounding the surgical
experience. Depending on medication selection, amne-
Analgesia
sia can be anterograde or retrograde. Benzodiazepine
Opioid medications such as fentanyl, hydromorphone, or medications and volatile anesthetic agents reliably
morphine are often used as part of a balanced anesthetic produce amnesia. Benzodiazepines administered in
low doses (midazolam 1–2 mg IV or diazepam 5–10 agents such as succinylcholine activate the motor end-
mg orally) have minimal respiratory depressant effects plate on skeletal muscle causing visual fasciculations
and are used in preprocedural sedation for regional followed by a period of flaccid paralysis lasting 6-12
nerve blocks or to reduce patient anxiety. minutes. Nondepolarizing medications (NDMR) such
as rocuronium or vecuronium are used during the
Neuromuscular Blocking induction of anesthesia or for maintenance muscle
There are two classes of neuromuscular blocking relaxation during surgery. Acetylcholinesterase inhib-
agents: depolarizing or nondepolarizing. Depolarizing itors, such as neostigmine, or binding agents such as
sugammadex, reverse the effects of NDMRs. Volatile
gases administered during anesthesia provide some
TABLE 3-3. Factors Predictive of (but not limited to) muscle relaxation, but also cause significant systemic
Difficult Airway Management
vascular vasodilation. Intravenous NDMR is hemody-
Small or receded Small mouth opening namically stable and allows for a reduction in volatile
mandible or maxilla gas concentration (balanced anesthetic approach).
(midface hypoplasia)
Large overbite History of difficult Vasopressors
intubation and/or mask
The use of vasopressor medications is common during
ventilation
anesthesia to reverse the vasodilatory and myocardial
Obesity Prominent maxillary teeth depressant effects of anesthetic agents. Phenylephrine
Short, thick neck Limited neck extension;
and ephedrine are commonly used for their vasocon-
prior neck fusion/fixation strictive and contractility augmenting effects, respec-
tively. Temporary use of vasopressors during periods
Poor dentition Head and neck tumors of surgical bleeding or restoration of intravascular
Facial trauma Maxillomandibular fixation volume is standard practice.
FIGURE 3-1. Mallampati Diagram. Reproduced with permission from Thomas J. Nuckton, David V. Glidden, Warren S. Browner, David
M. Claman. Physical Examination: Mallampati Score as an Independent Predictor of Obstructive Sleep Apnea. Sleep. 2006;29(7):903–908.
Oxford University Press.
from different classes. In modern anesthesia, this dioxide monitor, and temperature probe. Once opti-
is commonly accomplished with 5-HT3 antagonist mally positioned, the patient breathes 100% oxygen for
(ondansetron) and glucocorticoids (dexamethasone). several tidal volume breaths to denitrogenate the lungs
Other agents, such as transdermal scopolamine, (often referred to as preoxygenation). Preoxygenation
should be placed the night before surgery or a mini- is a critical step in the induction of anesthesia as a
mum of 3 hours before the procedure. Newer agents, patient will become apneic after anesthetic medica-
such as Aprepitant, have very high success rates to tion administration and may rapidly desaturate and
reduce PONV but may be cost-prohibitive. become hypoxic. After preoxygenation, medication
administration occurs in either a “rapid sequence”
INDUCTION OF ANESTHESIA fashion or “normal/routine sequence.” Rapid sequence
intubation describes administering medications to
The induction of anesthesia is the process of admin- produce unconsciousness and muscle relaxation and
istering medications to produce unconsciousness. then immediately placing an endotracheal tube (with-
Preparation for induction of general anesthesia out proving the ability to mask ventilate). Selection of
requires optimal patient positioning for intubation as rapid sequence intubation occurs when a patient is
well as placement of monitors such as pulse oximetry, having an urgent procedure and has been NPO for less
blood pressure cuff, EKG electrodes, end-tidal carbon than 6 hours, or where mask ventilation may increase
the chance of aspiration of stomach contents. A rou- alter the amounts of medications given on induction
tine intubation sequence occurs with mask ventilation or have the proper medications available to counter-
following the administration of anesthetic medica- act periods of low stimulation. The overall goal of
tions and loss of consciousness. A combination of induction is to safely and efficiently produce a state of
anesthetic medications is given depending on the level unconsciousness and analgesia sufficient for the pro-
of anesthesia required. Once the endotracheal tube cedure while maintaining the patient’s hemodynamics
is confirmed by auscultating the lungs for bilateral comparable to their baseline values.
breath sounds, verifying equal chest rise, and visualiz-
ing persistent end-tidal CO2 on the monitor, the oper- MAINTENANCE OF ANESTHESIA
ating room nursing staff begins skin preparation and
final positioning for surgery. The maintenance phase of anesthesia maintains a
level of patient unresponsiveness and relaxation that
Hemodynamic Concerns allows the performance of the surgical procedure
(Table 3-5). Maintenance involves the use of volatile
Following induction and intubation, patients display inhalational anesthetic gases and intravenous narcotic
hemodynamic changes consistent with the medica- medications.
tions delivered and airway management. Patients often
manifest a period of hypertension and tachycardia fol- Monitoring
lowing intubation and tracheal stimulation, followed
by a period of hypotension as they are “prepped and Patient monitoring during the maintenance of general
draped,” during which minimal stimulation occurs. anesthesia includes standard monitors recommended
The induction of anesthesia is a tumultuous period of by the American Society of Anesthesiologists and neu-
the anesthetic experience and requires the vigilance romuscular blockade monitoring (Table 3-6). Selective
and finesse of the anesthesia team. Seasoned and vigi- employment of anesthetic depth and invasive cardio-
lant anesthesia providers predict these hemodynamic vascular monitors, such as Bispectral Index, arterial
changes based on the comorbidities of the patient and lines, central venous catheters, and transesophageal
2 Excitation Excitation and delirium with struggling; coughing and vomiting possible;
rapid, irregular respirations; rapid eye movements; pupillary dilation;
divergent pupils; amnesia
3 Surgical Loss of consciousness; loss of touch sensation; amnesia; divided into four
anesthesia planes of increasing depth:
TABLE 3-6. ASA Standard Monitors setting. Liberal fluid management is associated with
worsened outcomes in more complex patients and
Oxygenation: inspired oxygen-gas concentrations, procedures, such as colon resection. Restrictive or
including a low oxygen concentration alarm
zero-balance fluid management seeks to replace only
Continuous end-tidal carbon dioxide fluid loss during surgery as well as a maintenance crys-
talloid infusion of 1-3 mL/kg/h to replace sensible and
Noninvasive blood pressure at least every 5 minutes insensible fluid loss. Restrictive fluid management has
Continuous electrocardiogram a higher association with postoperative acute kidney
injury than liberal or goal-directed strategies.3
Body temperature
Supraclavicular
Infraclavicular
Axillary
Paravertebral
Epidural